MedPath

The Chinese University of Hong Kong

The Chinese University of Hong Kong logo
🇨🇳China
Ownership
Private
Established
1963-01-01
Employees
-
Market Cap
-
Website
http://www.cuhk.edu.hk

Hepatocellular Carcinoma (HCC)_Torisel_

Phase 1
Completed
Conditions
Inoperable HCC
Interventions
First Posted Date
2010-12-02
Last Posted Date
2016-09-28
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
46
Registration Number
NCT01251458
Locations
🇭🇰

Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, Hong Kong

Nasopharyngeal Carcinoma (NPC) Axitinib

Phase 2
Completed
Conditions
Recurrent or Metastatic NPC
Interventions
First Posted Date
2010-11-30
Last Posted Date
2017-04-25
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
37
Registration Number
NCT01249547
Locations
🇭🇰

Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, Hong Kong

Intermittent Versus Continuous Tarceva Study

Phase 2
Completed
Conditions
Metastatic Colorectal Cancer
Interventions
Drug: Chemotherapy
First Posted Date
2010-11-18
Last Posted Date
2012-11-22
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
60
Registration Number
NCT01243047
Locations
🇭🇰

Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, Hong Kong

Dysphagia Rehabilitation for Nasopharyngeal Carcinoma Patients Post Radiotherapy

Not Applicable
Conditions
Nasopharyngeal Carcinoma
Radiotherapy
Interventions
Behavioral: Traditional rehabilitation (TR)
Behavioral: Transcutaneous electrical stimulation (ES)
First Posted Date
2010-11-10
Last Posted Date
2013-02-26
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
160
Registration Number
NCT01237704
Locations
🇭🇰

Prince of Wales Hospital, Shatin, New Territories, Hong Kong

🇭🇰

Queen Elizabeth Hospital, Kowloon, Hong Kong

Spinal met_radiosurgery/SBRT Study

Phase 2
Completed
Conditions
Spine Metastasis
Interventions
Radiation: SBRT
Radiation: Radiosurgery
First Posted Date
2010-11-01
Last Posted Date
2014-07-24
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
1
Registration Number
NCT01231061
Locations
🇭🇰

Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong, Hong Kong

Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial

Phase 3
Completed
Conditions
Biopsy-confirmed IgA Nephropathy
Proteinuria Less Than 0.5 g Per Day
Normal Blood Pressure
Serum Creatinine Below 120 Umol/l
Interventions
First Posted Date
2010-10-21
Last Posted Date
2010-10-21
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
60
Registration Number
NCT01225445
Locations
🇭🇰

Department of Medicine & Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong

Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS)

Phase 4
Completed
Conditions
Ankylosing Spondylitis(AS)
Interventions
Other: 0.9ml sodium chloride
First Posted Date
2010-10-01
Last Posted Date
2014-09-11
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
50
Registration Number
NCT01212653
Locations
🇨🇳

Prince of Wales Hospital, Hong Kong, China

Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis

Not Applicable
Completed
Conditions
Nonalcoholic Fatty Liver Disease
Interventions
Drug: Placebo
Drug: Phyllanthus urinaria
First Posted Date
2010-09-29
Last Posted Date
2014-02-24
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
60
Registration Number
NCT01210989
Locations
🇨🇳

Cheng Suen Man Shook Hepatitis Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China

Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis

Phase 4
Completed
Conditions
Lupus Nephritis
Interventions
Drug: Long-acting tacrolimus (Advagraf, Astellas Pharma)
First Posted Date
2010-09-22
Last Posted Date
2012-12-04
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
2
Registration Number
NCT01206569
Locations
🇭🇰

Prince of Wales Hospital, Shatin, Hong Kong

A Randomised Controlled Trial on LESS Versus Conventional Laparoscopic Appendicectomy.

Phase 3
Completed
Conditions
Appendicitis
Interventions
Procedure: LESS appendectomy
Procedure: Conventional 3-port laparoscopic appendectomy
First Posted Date
2010-09-16
Last Posted Date
2011-07-21
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
200
Registration Number
NCT01203566
Locations
🇨🇳

Department of Surgery, Prince of Wales Hospital, Shatin, Hong Kong, China

🇨🇳

Deparment of Surgery, North District Hospital, Sheung Shui, Hong Kong, China

© Copyright 2025. All Rights Reserved by MedPath